European authorities crack down on blood pressure medicine made by Mylan

REUTERS: European Union authorities are cracking down on blood pressure medicine valsartan made by a unit of Mylan NV after an impurity was found in some batches of the treatment.

The batches affected were made in Mylan’s Hyderabad facility in India and were found to contain N-nitrosodiethylamine (NDEA), a carcinogen, the European Medicines Agency said https://www.ema.europa.eu/en/news/valsartan-mylan-laboratories-india-can-no-longer-be-used-eu-medicines-due-ndea-impurity on Monday.

Leave a Reply

Your email address will not be published. Required fields are marked *